Kazia Therapeutics Analyst Ratings
BenzingaJul 12 18:40
Buy Rating on Kazia Therapeutics Backed by Promising GBM Study Results and Strong Financial Valuation
TipRanksJul 12 18:19
HC Wainwright & Co. Upgrades Kazia Therapeutics to Buy, Announces $2 Price Target
BenzingaApr 11, 2023 18:20